Adeoye Olukotun - Sep 13, 2021 Form 4 Insider Report for ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Role
Director
Signature
/s/Adeoye Olukotun
Stock symbol
ARWR
Transactions as of
Sep 13, 2021
Transactions value $
-$318,800
Form type
4
Date filed
9/14/2021, 05:25 PM
Previous filing
May 12, 2021
Next filing
Jan 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARWR Common Stock Sale -$143K -2.25K -16.07% $63.76 11.8K Sep 13, 2021 Direct F1, F2
transaction ARWR Common Stock Sale -$175K -2.75K -23.4% $63.76 9K Sep 13, 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The sale was made to generate proceeds to cover the tax liability incident to the vesting of restricted stock units.
F2 Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.